Defective N-linked protein glycosylation pathway in congenital myasthenic syndromes

Brain

Volumn 136, Issue 3, 2013, Pages 692-693

  Houlden, Henry ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; ACETYLCHOLINESTERASE;

ALG14 GENE; ALG2 GENE; CONGENITAL MYASTHENIC SYNDROME; DEPOLARIZATION; DPAGT1 GENE; GENE; GENE DELETION; GENE EXPRESSION; GENE INSERTION; GENOME ANALYSIS; GFPT1 GENE; HUMAN; INTRON; MISSENSE MUTATION; NEUROTRANSMISSION; NOTE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN GLYCOSYLATION; SYNAPTIC TRANSMISSION;

EID: 84874844265     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awt042     Document Type: Note

References (11)

1. Abicht A, Dusl M, Gallenmüller C, Guergueltcheva V, Schara U, Della Marina A, et al. Congenital myasthenic syndromes: achievements and limitations of phenotype-guided gene-after-gene sequencing in diagnostic practice: a study of 680 patients. Hum Mutat 2012; 33: 1474-84.
2. Beeson D. congenital myasthenic syndromes. ACNR Rev 2012; 11: 10-14.
3. Belaya K, Finlayson S, Slater C, Cossins J, Liu WW, Maxwell S, et al. Mutations in DPAGT1 cause a limb-girdle congenital myasthenic syndrome with tubular aggregates. Am J Hum Genet 2012; 91: 193-201.
4. Chaouch A, Beeson D, Hantai D, Lochmuller H. 186th ENMC International Workshop: congenital myasthenic syndromes 24-26 June 2011, Naarden, The Netherlands. Neuromuscul Disord 2012; 22: 566-76.
5. Cossins J, Belaya K, Hicks D, Salih MA, Finlayson S, Carboni N, et al. Congenital myasthenic syndromes due to mutations in ALG2 and ALG14. Brain 2013; 136: 944-56.
6. Engel AG. Current status of the congenital myasthenic syndromes. Neuromuscular Disord 2012; 22: 99-111.
7. Larkin A, Imperiali B. The expanding horizons of asparagine-linked glycosylation. Biochemistry 2011; 50: 4411-26.
8. Lorenzoni PJ, Scola RH, Kay CS, Werneck LC. Congenital myasthenic syndrome: a brief review. Pediatr Neurol 2012; 46: 141-8.
9. Senderek J, Muller JS, Dusl M, Strom TM, Guergueltcheva V, Diepolder I, et al. Hexosamine biosynthetic pathway mutations cause neuromuscular transmission defect. Am J Hum Genet 2011; 88: 162-72.
10. Thiel C, Schwarz M, Peng J, Grzmil M, Hasilik M, Braulke T, et al. A new type of congenital disorders of glycosylation (CDG-Ii) provides new insights into the early steps of dolichol-linked oligosaccharide biosynthesis. J Biol Chem 2003; 278: 22498-505.
11. Wurde AE, Reunert J, Rust S, Hertzberg C, Haverkamper S, Nurnberg G, et al. Congenital disorder of glycosylation type Ij (CDG-Ij, DPAGT1-CDG): Extending the clinical and molecular spectrum of a rare disease. Mol Genet Metab 2012; 105: 634-41.